Non-Medically Important Antibiotics: Tyson Foods To Reintroduce Certain Antibiotics To Chicken Production: Report
Portfolio Pulse from Vandana Singh
Tyson Foods, Inc. (NYSE:TSN) plans to reintroduce certain antibiotics, specifically ionophores, into its chicken supply chain by the end of the year. This move is expected to be cost-saving for Tyson, as consumers show less willingness to pay extra for antibiotic-free products. The FDA supports limited antibiotic use in meat production, noting that antibiotics like ionophores represent a significantly lower risk of developing drug-resistant bacteria. Tyson's shares are up 0.37% at $51.23 during the premarket session.
July 03, 2023 | 1:02 pm
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
Tyson Foods' decision to reintroduce certain antibiotics into its chicken supply chain could be cost-saving and may improve the health of farmers' flocks. This move is seen as a positive for animal welfare and is supported by the FDA.
The reintroduction of certain antibiotics into Tyson Foods' chicken supply chain is expected to save costs for the company, as consumers are less willing to pay extra for antibiotic-free products. This move is also seen as a positive for animal welfare and is supported by the FDA, which could boost investor confidence in the company. As a result, Tyson's stock price could see a positive impact in the short term.
CONFIDENCE 90
IMPORTANCE 75
RELEVANCE 100